Nordic Walk on Balance and Functional Strength in Children With Down Syndrome
Down syndrome (DS) is one of the more commonly occurring genetic disorders, where mental retardation is combined with nutritional diseases. It is caused by having a third copy of chromosome 21, and there exist 3 forms; Simple Trisomy 21, Translocation Trisomy and Mosaic Trisomy. It is coupled with mental retardation, c
| Condition(s) | Down Syndrome |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Down syndrome (DS) is one of the more commonly occurring genetic disorders, where mental retardation is combined with nutritional diseases. It is caused by having a third copy of chromosome 21, and there exist 3 forms; Simple Trisomy 21, Translocation Trisomy and Mosaic Trisomy. It is coupled with mental retardation, congenital heart defects, gastrointestinal anomalies .Nordic walking exerts beneficial effects on resting heart rate, blood pressure, exercise capacity, maximal oxygen consumption, and quality of life in patients with various diseases and can thus be recommended to a wide range of people as primary and secondary prevention. This study will aim to examine the effects of Nordic walk on balance and functional strength in children with Down syndrome. A Randomized Controlled Trial |
| Who can participate | Inclusion Criteria: * Children with age group of 8-13 * Both male and female * Functional ability sufficient enough to understand commands, direction and exercise guidance * Have ability to walk 60 meters independently according to 6- minute walk test * Children who can stand and walk with balance problem as revealed from physical examination having 20 to 42 scores on PBS. Exclusion Criteria: Uncontrolled seizures * Any kind of orthopedic condition * Registered visually impaired * Atlanto Axial instability * Any chest infection |
| Ages | 8 Years to 13 Years |
| Sex | All |
| Lead sponsor | Riphah International University |
| Locations | Lahore, Punjab Province, Pakistan |
| Start date | 2025-04-15 |
| NCT ID | NCT06943508 |
| Official listing | https://clinicaltrials.gov/study/NCT06943508 |